
Annual report 2022
added 03-30-2023
Apollo Endosurgery Market Cap 2011-2026 | APEN
As of March 25, 2026 Apollo Endosurgery has a market cap of $ 475 M
Capitalization is the market value of a company whose shares are traded on the stock exchange. It is calculated by multiplying the market price of a share by the total number of the company's shares. Capitalization indicates volatility, risk, and growth potential. This metric is often used for a quick assessment of a company’s investment profile.[1]
Capitalization is an important indicator for investors and analysts, as it helps determine the size and significance of a company in the stock market. Companies with large capitalization are considered more stable and reliable, as they have more resources and financial power to grow and survive in the market.
This metric can be divided into several categories: small (from 300 million to 2 billion dollars), medium (from 2 to 10 billion dollars), and large (over 10 billion dollars). Companies with different levels of capitalization have their own characteristics and risks, so investors usually take this indicator into account when making investment decisions.
Capitalization can also change over time depending on the share price and the number of shares in circulation. Therefore, it is a dynamic indicator that requires constant monitoring and analysis to make well-informed investment decisions.
Annual Market Cap Apollo Endosurgery
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 403 M | 167 M | 94.9 M | 64 M | 70.3 M | 83.3 M | 5.12 M | 5.15 M | 47.2 M | 64.1 M | 53.1 M | 59.8 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 403 M | 5.12 M | 93 M |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.
Market Cap of other stocks in the Medical devices industry
| Issuer | Market Cap | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
GenMark Diagnostics, Inc.
GNMK
|
933 M | - | - | $ 1.77 B | ||
|
Axonics Modulation Technologies
AXNX
|
2.82 B | - | - | $ 3.31 B | ||
|
Lianluo Smart Limited
LLIT
|
147 M | - | 24.59 % | $ 44.8 M | ||
|
Aziyo Biologics
AZYO
|
26.9 M | - | 1.37 % | $ 20.5 M | ||
|
Acutus Medical
AFIB
|
5.24 M | - | -26.83 % | $ 2.62 M | ||
|
Allied Healthcare Products
AHPI
|
4.01 M | - | 3.58 % | $ 2.21 M | ||
|
Obalon Therapeutics, Inc.
OBLN
|
35 M | - | -5.86 % | $ 30.6 M | ||
|
BioSig Technologies
BSGM
|
7.3 M | - | 37.08 % | $ 85.7 M | ||
|
Conformis
CFMS
|
12.6 M | - | - | $ 16.4 M | ||
|
Cardiovascular Systems
CSII
|
588 M | - | 0.15 % | $ 844 M | ||
|
IRIDEX Corporation
IRIX
|
48.1 M | $ 1.35 | - | $ 21.8 M | ||
|
Orthofix Medical
OFIX
|
491 M | $ 11.72 | -1.26 % | $ 464 M | ||
|
LENSAR
LNSR
|
130 M | $ 5.56 | -8.4 % | $ 64 M | ||
|
Avinger
AVGR
|
2.59 M | - | -20.74 % | $ 369 K | ||
|
CryoLife, Inc.
CRY
|
906 M | - | -4.14 % | $ 702 M | ||
|
CHF Solutions, Inc.
CHFS
|
1.05 M | - | 1.15 % | $ 34.5 M | ||
|
AxoGen
AXGN
|
1.5 B | $ 32.61 | 2.71 % | $ 1.5 B | ||
|
CONMED Corporation
CNMD
|
1.32 B | $ 36.56 | -0.19 % | $ 1.13 B | ||
|
Penumbra
PEN
|
13.2 B | $ 334.17 | -0.41 % | $ 13 B | ||
|
Soliton, Inc.
SOLY
|
229 M | - | -1.42 % | $ 435 M | ||
|
Hancock Jaffe Laboratories, Inc.
HJLI
|
7.99 M | - | -1.98 % | $ 98.3 M | ||
|
Itamar Medical Ltd.
ITMR
|
339 M | - | 0.03 % | $ 1.58 B | ||
|
Electromed
ELMD
|
175 M | $ 24.7 | 0.86 % | $ 209 M | ||
|
Misonix, Inc.
MSON
|
185 M | - | - | $ 462 M | ||
|
Neovasc
NVCN
|
677 M | - | - | $ 111 M | ||
|
Insulet Corporation
PODD
|
18.1 B | $ 225.5 | -0.7 % | $ 15.9 B | ||
|
Intersect ENT, Inc.
XENT
|
735 M | - | - | $ 955 M | ||
|
Cytosorbents Corporation
CTSO
|
54.4 M | $ 0.7 | 3.3 % | $ 38.1 M | ||
|
Aethlon Medical
AEMD
|
3.03 M | $ 2.16 | -6.09 % | $ 3.37 M | ||
|
Profound Medical Corp.
PROF
|
230 M | $ 5.15 | -4.63 % | $ 180 M | ||
|
BIOLASE
BIOL
|
192 K | - | -13.19 % | $ 166 K | ||
|
Quanterix Corporation
QTRX
|
269 M | $ 3.82 | -3.05 % | $ 163 M | ||
|
AdaptHealth Corp.
AHCO
|
1.2 B | $ 11.48 | 10.7 % | $ 1.55 B | ||
|
Myomo
MYO
|
33.9 M | $ 0.7 | -1.83 % | $ 29.3 M | ||
|
Nano-X Imaging Ltd.
NNOX
|
258 M | $ 2.4 | -1.64 % | $ 141 M | ||
|
Invacare Corporation
IVC
|
24.1 M | - | - | $ 24.7 M | ||
|
EDAP TMS S.A.
EDAP
|
60 M | $ 3.91 | 4.83 % | $ 146 M | ||
|
OrthoPediatrics Corp.
KIDS
|
437 M | $ 15.91 | -3.4 % | $ 373 M | ||
|
Outset Medical
OM
|
52.5 K | $ 3.53 | -2.35 % | $ 53.7 K | ||
|
Inspire Medical Systems
INSP
|
1.76 B | $ 52.07 | -0.17 % | $ 1.53 B | ||
|
Sintx Technologies
SINT
|
6.91 M | $ 2.57 | 0.78 % | $ 7.13 M | ||
|
Pulmonx Corporation
LUNG
|
72.8 M | $ 1.31 | -5.76 % | $ 53.3 M | ||
|
Cutera
CUTR
|
46.5 M | - | -10.19 % | $ 1.99 M | ||
|
Dynatronics Corporation
DYNT
|
1.95 M | - | 14.99 % | $ 929 K | ||
|
Sensus Healthcare
SRTS
|
72.3 M | $ 3.96 | -3.65 % | $ 64.7 M | ||
|
InspireMD
NSPR
|
115 M | $ 1.79 | 3.47 % | $ 115 M | ||
|
Eargo
EAR
|
17 M | - | - | $ 10.2 M | ||
|
NuVasive
NUVA
|
2.29 B | - | - | $ 2.07 B | ||
|
Second Sight Medical Products
EYES
|
225 K | - | -0.97 % | $ 54.4 M |